Abstract
Diagnostic procedures of noninvasive assessment for patients with peripheral artery disease (PAD) have been advancing for decades. Among diagnostic imaging modalities, lower-limb perfusion (LLP) planar scintigraphy and SPECT/CT are exclusively used for diagnosing lower-limb ischemia, therapeutic efficacies, and risk stratification in PAD patients. Of these modalities, LLP SPECT/CT particularly shows more accuracy in providing quantitative assessment of LLP using innovative imaging devices and dedicated software.